• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-34-CSF1R 信号轴促进上皮细胞转化和乳腺癌发生。

Interleukin-34-CSF1R Signaling Axis Promotes Epithelial Cell Transformation and Breast Tumorigenesis.

机构信息

College of Pharmacy, Chosun University, Gwangju 61452, Korea.

出版信息

Int J Mol Sci. 2021 Mar 8;22(5):2711. doi: 10.3390/ijms22052711.

DOI:10.3390/ijms22052711
PMID:33800170
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7962444/
Abstract

IL-34 has been recently identified as a ligand for CSF1R that regulates various cellular processes including cell proliferation, survival, and differentiation. Although the binding of IL-34 to CSF1R modulates several cancer-driving signaling pathways, little is known about the role of IL-34/CSF1R signaling in breast cancer. Herein, we report that IL-34 induces epithelial cell transformation and breast tumorigenesis through activation of MEK/ERK and JNK/c-Jun pathways. IL-34 increased the phosphorylation of MEK1/2, ERK1/2, JNK1/2, and c-Jun through CSF1R in mouse skin epidermal JB6 C141 cells and human breast cancer MCF7 cells. IL-34 enhanced c-Fos and c-Jun promoter activity, resulting in increased AP-1 transactivation activity in JB6 Cl41 and MCF7 cells. Moreover, PIN1 enhanced IL-34-induced phosphorylation of MEK1/2, ERK1/2, JNK1/2, and c-Jun in JB6 Cl41 and MCF7 cells. Inhibition of PIN1 using juglone prevented the IL-34-induced transformation of JB6 C141 cells. Similarly, silencing of PIN1 reduced the IL-34-induced tumorigenicity of MCF7 cells. Consistent with these results, the synergistic model showed that treatment with juglone suppressed the IL-34-induced growth of tumors formed by 4T1 cells in BALB/c mice. Our study demonstrates the role of IL-34-induced MEK/ERK and JNK/c-Jun cascades in breast cancer and highlights the regulatory role of PIN1 in IL-34-induced breast tumorigenesis.

摘要

白细胞介素 34(IL-34)最近被鉴定为 CSF1R 的配体,调节包括细胞增殖、存活和分化在内的各种细胞过程。虽然 IL-34 与 CSF1R 的结合调节了几个促进癌症的信号通路,但对于 IL-34/CSF1R 信号在乳腺癌中的作用知之甚少。在此,我们报告 IL-34 通过激活 MEK/ERK 和 JNK/c-Jun 途径诱导上皮细胞转化和乳腺癌发生。IL-34 通过 CSF1R 在小鼠皮肤表皮 JB6 C141 细胞和人乳腺癌 MCF7 细胞中增加 MEK1/2、ERK1/2、JNK1/2 和 c-Jun 的磷酸化。IL-34 增强了 c-Fos 和 c-Jun 启动子活性,导致 JB6 Cl41 和 MCF7 细胞中 AP-1 转录激活活性增加。此外,PIN1 增强了 JB6 Cl41 和 MCF7 细胞中 IL-34 诱导的 MEK1/2、ERK1/2、JNK1/2 和 c-Jun 的磷酸化。使用胡桃醌抑制 PIN1 可防止 IL-34 诱导的 JB6 C141 细胞转化。同样,沉默 PIN1 降低了 IL-34 诱导的 MCF7 细胞的致瘤性。与这些结果一致,协同模型表明,用胡桃醌处理可抑制 IL-34 诱导的 BALB/c 小鼠 4T1 细胞形成的肿瘤的生长。我们的研究表明 IL-34 诱导的 MEK/ERK 和 JNK/c-Jun 级联在乳腺癌中的作用,并强调了 PIN1 在 IL-34 诱导的乳腺癌发生中的调节作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b94/7962444/c1916e036b38/ijms-22-02711-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b94/7962444/c7f185d1a3fc/ijms-22-02711-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b94/7962444/776adecada14/ijms-22-02711-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b94/7962444/4734849fc4f4/ijms-22-02711-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b94/7962444/9b542b0d56ee/ijms-22-02711-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b94/7962444/6328f5da66bf/ijms-22-02711-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b94/7962444/c1916e036b38/ijms-22-02711-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b94/7962444/c7f185d1a3fc/ijms-22-02711-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b94/7962444/776adecada14/ijms-22-02711-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b94/7962444/4734849fc4f4/ijms-22-02711-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b94/7962444/9b542b0d56ee/ijms-22-02711-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b94/7962444/6328f5da66bf/ijms-22-02711-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b94/7962444/c1916e036b38/ijms-22-02711-g006.jpg

相似文献

1
Interleukin-34-CSF1R Signaling Axis Promotes Epithelial Cell Transformation and Breast Tumorigenesis.白细胞介素-34-CSF1R 信号轴促进上皮细胞转化和乳腺癌发生。
Int J Mol Sci. 2021 Mar 8;22(5):2711. doi: 10.3390/ijms22052711.
2
Interleukin-22 promotes epithelial cell transformation and breast tumorigenesis via MAP3K8 activation.白细胞介素-22通过激活MAP3K8促进上皮细胞转化和乳腺肿瘤发生。
Carcinogenesis. 2014 Jun;35(6):1352-61. doi: 10.1093/carcin/bgu044. Epub 2014 Feb 11.
3
Regulation of Interleukin-36γ/IL-36R Signaling Axis by PIN1 in Epithelial Cell Transformation and Breast Tumorigenesis.PIN1对白细胞介素-36γ/IL-36R信号轴在上皮细胞转化和乳腺肿瘤发生中的调控作用
Cancers (Basel). 2022 Jul 27;14(15):3654. doi: 10.3390/cancers14153654.
4
Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity.白细胞介素-17 通过上调肿瘤进展相关基因 2 的活性诱导 AP-1 活性和细胞转化。
Carcinogenesis. 2013 Feb;34(2):341-50. doi: 10.1093/carcin/bgs342. Epub 2012 Nov 3.
5
The prolyl isomerase Pin1 enhances HER-2 expression and cellular transformation via its interaction with mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1.脯氨酰异构酶 Pin1 通过与丝裂原活化蛋白激酶/细胞外信号调节激酶激酶 1 的相互作用增强 HER-2 的表达和细胞转化。
Mol Cancer Ther. 2010 Mar;9(3):606-16. doi: 10.1158/1535-7163.MCT-09-0560. Epub 2010 Feb 23.
6
Dipeptidyl peptidase 4 promotes epithelial cell transformation and breast tumourigenesis via induction of PIN1 gene expression.二肽基肽酶4通过诱导PIN1基因表达促进上皮细胞转化和乳腺肿瘤发生。
Br J Pharmacol. 2015 Nov;172(21):5096-109. doi: 10.1111/bph.13274. Epub 2015 Oct 16.
7
COT phosphorylates prolyl-isomerase Pin1 to promote tumorigenesis in breast cancer.COT使脯氨酰异构酶Pin1磷酸化,以促进乳腺癌的肿瘤发生。
Mol Carcinog. 2015 Jun;54(6):440-8. doi: 10.1002/mc.22112. Epub 2013 Nov 22.
8
Pin1 is required for ultraviolet A-stimulated cyclooxygenase-2 induction in mouse epidermal cells.Pin1 对于紫外线 A 刺激的小鼠表皮细胞中环氧化酶-2 的诱导是必需的。
Cancer Lett. 2013 Jul 10;335(1):31-40. doi: 10.1016/j.canlet.2013.01.047. Epub 2013 Feb 1.
9
Interleukin-33/ST2 axis promotes epithelial cell transformation and breast tumorigenesis via upregulation of COT activity.白细胞介素-33/ST2轴通过上调COT活性促进上皮细胞转化和乳腺肿瘤发生。
Oncogene. 2015 Sep 17;34(38):4928-38. doi: 10.1038/onc.2014.418. Epub 2014 Dec 22.
10
The prolyl isomerase Pin1 interacts with a ribosomal protein S6 kinase to enhance insulin-induced AP-1 activity and cellular transformation.脯氨酰异构酶Pin1与核糖体蛋白S6激酶相互作用,以增强胰岛素诱导的AP-1活性和细胞转化。
Carcinogenesis. 2009 Apr;30(4):671-81. doi: 10.1093/carcin/bgp027. Epub 2009 Jan 23.

引用本文的文献

1
Targeting the IL34-CSF1R axis improves metastatic renal cell carcinoma therapy outcome via immune-vascular crosstalk regulation.靶向IL34-CSF1R轴通过免疫-血管串扰调节改善转移性肾细胞癌的治疗结果。
iScience. 2025 May 26;28(6):112752. doi: 10.1016/j.isci.2025.112752. eCollection 2025 Jun 20.
2
CSF-1R in Cancer: More than a Myeloid Cell Receptor.癌症中的集落刺激因子1受体:不仅仅是一种髓样细胞受体。
Cancers (Basel). 2024 Jan 9;16(2):282. doi: 10.3390/cancers16020282.
3
[Expression of interleukin-34 in tongue squamous cell carcinoma and its clinical implications].

本文引用的文献

1
Role of Interleukin-34 in Cancer.白细胞介素-34在癌症中的作用。
Cancers (Basel). 2020 Jan 20;12(1):252. doi: 10.3390/cancers12010252.
2
Emerging roles of IL-34 in health and disease.IL-34 在健康和疾病中的新作用。
J Exp Med. 2020 Mar 2;217(3). doi: 10.1084/jem.20190290.
3
Immunomodulation of Interleukin-34 and its Potential Significance as a Disease Biomarker and Therapeutic Target.白细胞介素-34 的免疫调节及其作为疾病生物标志物和治疗靶点的潜在意义。
[白细胞介素-34在舌鳞状细胞癌中的表达及其临床意义]
Nan Fang Yi Ke Da Xue Xue Bao. 2023 Dec 20;43(12):2111-2117. doi: 10.12122/j.issn.1673-4254.2023.12.16.
4
Interleukin-34 and immune checkpoint inhibitors: Unified weapons against cancer.白细胞介素-34与免疫检查点抑制剂:对抗癌症的联合武器。
Front Oncol. 2023 Jan 31;13:1099696. doi: 10.3389/fonc.2023.1099696. eCollection 2023.
5
Targeted Therapy of Interleukin-34 as a Promising Approach to Overcome Cancer Therapy Resistance.靶向白细胞介素-34治疗:克服癌症治疗耐药性的一种有前景的方法
Cancers (Basel). 2023 Feb 3;15(3):971. doi: 10.3390/cancers15030971.
6
Regulation of Interleukin-36γ/IL-36R Signaling Axis by PIN1 in Epithelial Cell Transformation and Breast Tumorigenesis.PIN1对白细胞介素-36γ/IL-36R信号轴在上皮细胞转化和乳腺肿瘤发生中的调控作用
Cancers (Basel). 2022 Jul 27;14(15):3654. doi: 10.3390/cancers14153654.
7
IL-34 Aggravates Steroid-Induced Osteonecrosis of the Femoral Head via Promoting Osteoclast Differentiation.白细胞介素-34通过促进破骨细胞分化加重类固醇诱导的股骨头坏死。
Immune Netw. 2022 Mar 31;22(3):e25. doi: 10.4110/in.2022.22.e25. eCollection 2022 Jun.
8
Multi-Omics Analyses Revealed GOLT1B as a Potential Prognostic Gene in Breast Cancer Probably Regulating the Immune Microenvironment.多组学分析揭示GOLT1B作为乳腺癌潜在的预后基因,可能调控免疫微环境。
Front Oncol. 2022 Jan 19;11:805273. doi: 10.3389/fonc.2021.805273. eCollection 2021.
Int J Biol Sci. 2019 Jul 20;15(9):1835-1845. doi: 10.7150/ijbs.35070. eCollection 2019.
4
c-Fos induces chondrogenic tumor formation in immortalized human mesenchymal progenitor cells.c-Fos 诱导永生化人间充质祖细胞形成软骨瘤。
Sci Rep. 2018 Oct 23;8(1):15615. doi: 10.1038/s41598-018-33689-0.
5
Serum interleukin-34 levels in patients with systemic sclerosis: Clinical association with interstitial lung disease.系统性硬化症患者血清白细胞介素-34 水平:与间质性肺病的临床相关性。
J Dermatol. 2018 Oct;45(10):1216-1220. doi: 10.1111/1346-8138.14538. Epub 2018 Jul 13.
6
IL-34 regulates IL-6 and IL-8 production in human lung fibroblasts via MAPK, PI3K-Akt, JAK and NF-κB signaling pathways.IL-34 通过 MAPK、PI3K-Akt、JAK 和 NF-κB 信号通路调节人肺成纤维细胞中 IL-6 和 IL-8 的产生。
Int Immunopharmacol. 2018 Aug;61:119-125. doi: 10.1016/j.intimp.2018.05.023. Epub 2018 May 30.
7
Differential prognostic impact of interleukin-34 mRNA expression and infiltrating immune cell composition in intrinsic breast cancer subtypes.白细胞介素-34 mRNA 表达及浸润性免疫细胞组成在原发性乳腺癌亚型中的差异预后影响
Oncotarget. 2018 May 1;9(33):23126-23148. doi: 10.18632/oncotarget.25226.
8
Inflammatory breast cancer biology: the tumour microenvironment is key.炎性乳腺癌生物学:肿瘤微环境是关键。
Nat Rev Cancer. 2018 Aug;18(8):485-499. doi: 10.1038/s41568-018-0010-y.
9
Interleukin-34 sustains pro-tumorigenic signals in colon cancer tissue.白细胞介素-34维持结肠癌组织中的促肿瘤信号。
Oncotarget. 2017 Dec 15;9(3):3432-3445. doi: 10.18632/oncotarget.23289. eCollection 2018 Jan 9.
10
High co-expression of IL-34 and M-CSF correlates with tumor progression and poor survival in lung cancers.IL-34 和 M-CSF 的高共表达与肺癌的肿瘤进展和不良预后相关。
Sci Rep. 2018 Jan 11;8(1):418. doi: 10.1038/s41598-017-18796-8.